Thursday, November 19, 2026 | 10:56 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sanket Koul

Sanket Koul

Sanket Koul

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.

Email

Sanket Koul

Centre proposes separate wholesale licensing framework for bulk drugs

Move comes amid concerns over safety lapses involving contaminated solvents

Centre proposes separate wholesale licensing framework for bulk drugs
Updated On : 19 Nov 2026 | 10:38 PM IST

Centre proposes central approval for antimicrobials amid AMR concerns

The proposed amendment would bring antibiotics, antivirals and antifungals under the Central Licensing Authority, strengthening requirements for safety, efficacy and bioequivalence data

Centre proposes central approval for antimicrobials amid AMR concerns
Updated On : 19 Nov 2026 | 8:02 PM IST

NPPA extends knee implant price ceiling till January 2027 amid mark-up row

Drug price regulator extends knee implant price caps for two months as manufacturers seek revisions, while domestic medtech firms call for stability and a review of trade margins

NPPA extends knee implant price ceiling till January 2027 amid mark-up row
Updated On : 16 Nov 2026 | 8:20 PM IST

Govt, pvt health insurance spending crosses 20% of total health expenditure

Government-funded health schemes and private insurance accounted for 21.2 per cent of India's total health expenditure in FY24, with both categories crossing 10 per cent for the first time

Govt, pvt health insurance spending crosses 20% of total health expenditure
Updated On : 15 Nov 2026 | 10:50 PM IST

India's first Zika vaccine nears human trials after CDSCO panel review

An expert committee has recommended Phase I clinical trials for the vaccine developed by Indian Immunologicals and Australia's Griffith University, following a review of non-clinical studies

India's first Zika vaccine nears human trials after CDSCO panel review
Updated On : 15 Nov 2026 | 12:14 PM IST

Revamped medical device PLI to boost localisation, widen manufacturing base

Revised scheme brings component makers and MSMEs into the incentive framework, with higher incentives for critical components and high-end devices to deepen localisation

Revamped medical device PLI to boost localisation, widen manufacturing base
Updated On : 13 Nov 2026 | 11:05 PM IST

Centre directs states to monitor compliance with cancer drug margin caps

Drug pricing regulator NPPA asks state drug controllers to submit action-taken reports by November 16 as a 30 per cent trade margin cap on 137 cancer drugs takes effect

Centre directs states to monitor compliance with cancer drug margin caps
Updated On : 13 Nov 2026 | 6:14 PM IST

India records 38% drop in TB deaths since 2015, outpaces global rate: WHO

Despite progress, India still had the highest TB burden, accounting for almost a quarter of global cases in 2025

India records 38% drop in TB deaths since 2015, outpaces global rate: WHO
Updated On : 13 Nov 2026 | 12:32 AM IST

Medical device PLI scheme extended by 8 years; focus shifts to components

The revised scheme removes the minimum sales threshold, lowers investment requirements and offers higher incentives for critical components and advanced medical devices

Medical device PLI scheme extended by 8 years; focus shifts to components
Updated On : 10 Nov 2026 | 10:41 PM IST

Delhi AQI worsens after Diwali; pollution sparks political blame game

Delhi's AQI touched 372 on Monday after Diwali celebrations, triggering health concerns, questions over pollution monitoring and a political row over stubble burning in Punjab

Delhi AQI worsens after Diwali; pollution sparks political blame game
Updated On : 10 Nov 2026 | 12:15 PM IST

Fortis Q2 net profit falls 2.5% on higher expenses, lower exceptional gain

Fortis Healthcare's Q2FY27 net profit declined to ₹320 crore as expenses rose, while revenue grew 17 per cent to ₹2,735 crore, driven by hospitals and diagnostics

Fortis Q2 net profit falls 2.5% on higher expenses, lower exceptional gain
Updated On : 05 Nov 2026 | 8:54 PM IST

Govt proposes immediate licence suspension for substandard drugmakers

The Health Ministry has proposed suspending manufacturing licences immediately after drugs fail critical quality tests, aiming to prevent unsafe medicines from remaining in circulation.

Govt proposes immediate licence suspension for substandard drugmakers
Updated On : 05 Nov 2026 | 12:04 AM IST

Stricter microbial contamination norms under Schedule M in offing

The Union Health Ministry has proposed tightening microbial contamination limits in Grade A clean areas to align India's pharmaceutical manufacturing standards with WHO guidelines

Stricter microbial contamination norms under Schedule M in offing
Updated On : 04 Nov 2026 | 11:09 PM IST

Manipal signs 30-year lease with Thakral for 500-bed Gurugram hospital

Manipal Health Enterprises will develop and operate a multi-specialty hospital on 3.5 acres in Gurugram under a 30-year lease, with the estimated investment pegged at ₹750 crore

Manipal signs 30-year lease with Thakral for 500-bed Gurugram hospital
Updated On : 04 Nov 2026 | 8:30 PM IST

Dr Lal PathLabs Q2 net profit rises 27.5% to ₹194 cr on volume growth

Dr Lal PathLabs reported a 19.6 per cent rise in Q2FY27 revenue to ₹874 crore as sample volumes grew 13.6 per cent and patient coverage increased 9 per cent

Dr Lal PathLabs Q2 net profit rises 27.5% to ₹194 cr on volume growth
Updated On : 04 Nov 2026 | 7:43 PM IST

Centre plans to expand import clearance gateways for drugs, medical devices

The Health Ministry proposes adding seven inland container depots, an SEZ and Jewar airport to the approved list to ease imports of drugs, medical devices and cosmetics

Centre plans to expand import clearance gateways for drugs, medical devices
Updated On : 03 Nov 2026 | 9:17 PM IST

Centre proposes mandatory qualified personnel for drug batch release

The proposed amendments seek to strengthen accountability in drug manufacturing by requiring qualified personnel for batch release and maintaining prescribed records

Centre proposes mandatory qualified personnel for drug batch release
Updated On : 03 Nov 2026 | 8:28 PM IST

Pharma industry seeks clarity on CDSCO solvent order's export ambit

Pharma executives seek clarity on export applicability of CDSCO's batch-wise solvent clearance rules, warning that approval delays could disrupt supplies, particularly in rural markets

Pharma industry seeks clarity on CDSCO solvent order's export ambit
Updated On : 03 Nov 2026 | 6:54 PM IST

CDSCO mandates digital batchwise clearance for high-risk pharma solvents

Drug regulator CDSCO has mandated digital clearance for every batch of high-risk pharmaceutical solvents, prompting industry concerns over delays and potential supply disruptions

CDSCO mandates digital batchwise clearance for high-risk pharma solvents
Updated On : 02 Nov 2026 | 10:38 PM IST

RPG Life Sciences eyes another acquisition with ₹500 crore capital pool

The drugmaker plans to deploy ₹500 crore for another acquisition within 12 months as it targets 25 per cent annual growth in its API business over the next five years

RPG Life Sciences eyes another acquisition with ₹500 crore capital pool
Updated On : 01 Nov 2026 | 6:21 PM IST